NYSE:PTN
Palatin Technologies Inc Stock News
$1.82
+0.100 (+5.81%)
At Close: Apr 26, 2024
Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q1 2022 Results - Earnings Call Transcript
12:33pm, Monday, 15'th Nov 2021
Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q1 2022 Results - Earnings Call Transcript
Palatin to Report First Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on November 15, 2021
04:30pm, Wednesday, 10'th Nov 2021
CRANBURY, N.J., Nov. 10, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its first quarter, fiscal year 2022 operating results on Monday, November 15, 2021, before
Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q4 2021 Results - Earnings Call Transcript
02:12pm, Wednesday, 29'th Sep 2021
Palatin Technologies, Inc. (PTN) CEO Carl Spana on Q4 2021 Results - Earnings Call Transcript
Palatin Reports Fourth Quarter and Full Year Fiscal Year 2021 Financial Results and Provides Corporate Update
07:30am, Wednesday, 29'th Sep 2021
CRANBURY, N.J., Sept. 29, 2021 /PRNewswire/ -- Palatin Technologies, Inc., (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the ac
CRANBURY, N.J., Sept. 27, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that mod
Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September 29, 2021
07:30am, Friday, 24'th Sep 2021
CRANBURY, N.J., Sept. 24, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its fourth quarter and fiscal year end 2021 operating results on Wednesday, September 29, 2
Palatin to Present Peptides Platform at the TIDES USA Conference
07:30am, Wednesday, 15'th Sep 2021
CRANBURY, N.J., Sept. 15, 2021 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that mod
Palatin Announces Presentation at the Eyecelerator@ASCRS Conference
05:28pm, Thursday, 22'nd Jul 2021
CRANBURY, N.J., July 22, 2021 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modul
Palatin Announces Adjournment of Annual Meeting of Stockholders
04:15pm, Thursday, 08'th Jul 2021
CRANBURY, N.J., July 8, 2021 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN) announced that its 2021 Annual Meeting of Stockholders that convened on June 8, 2021 and was a
7 Penny Stocks For Your Watch List This Week If You Like Biotech In July
12:29pm, Monday, 05'th Jul 2021
Looking for biotech penny stocks to watch right now? Here are 7 for your list this week.
What Penny Stocks Investors Need to Know in July and 7 Stocks to Watch
12:30pm, Saturday, 03'rd Jul 2021
What do you need to know about trading penny stocks in 2021? Here's 3 tips and 7 small-caps to watch The post What Penny Stocks Investors Need to Know in July and 7 Stocks to Watch appeared first on P
Palatin Technologies Stock Moves Higher After Outlining Plans For Dry Eye Disease Treatment
09:18am, Tuesday, 29'th Jun 2021
Palatin Technologies Inc (NYSE: PTN) has completed an End-of-Phase 2 (EOP2) meeting with the FDA for PL9643 for the treatment of dry eye disease (DED). Palatin remains on track to initiate the Phas
Palatin Announces Positive End-of-Phase 2 Meeting with FDA on PL9643 for the Treatment of Dry Eye Disease
07:30am, Tuesday, 29'th Jun 2021
CRANBURY, N.J., June 29, 2021 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN) a biopharmaceutical company developing first-in-class medicines based on molecules that modula
Palatin Announces New Additions to Its Senior Leadership Team
07:30am, Monday, 28'th Jun 2021
CRANBURY, N.J., June 28, 2021 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN) a biopharmaceutical company developing first-in-class medicines based on molecules that modula
Palatin Announces Adjournment of Annual Meeting of Stockholders
07:30am, Thursday, 10'th Jun 2021
CRANBURY, N.J., June 10, 2021 /PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN) announced that its 2021 Annual Meeting of Stockholders that convened on June 8, 2021, has been
